DOCUPRENE- docusate sodium tablet
Pharmaceutica North America, Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
Sodium Dioctyl Sulfosuccinate 100mg
Each tablet contains 8 mg. of Sodium
Dicalcium phosphate, microcrystalline cellulose, pregelatinized starch, croscamellose sodium, stearic acid, colloidal silicon dioxide, magnesium sterate, titanium dioxide, talc, hypromellose, polyethylene glycol, FDandC blue #1
For the prevention of dry hard stools
For relief of occasional constipation
This product generally produces bowel movement with 12 to 72 hours.
Warnings
Do not use laxative products for longer that one week unless directed to do so by a doctor and if you are presently taking mineral oil, unless told to do so by a doctor.
Ask a doctor before use if you have: Abdominal pain, nausea, vomiting, noticed a sudden change in bowel habits that persists over a period of 2 weeks. Stop use and ask a doctor if: You have rectal bleeding or if you fail to have a bowel movement after use. These could be signs of a serious condition.
If pregnant or breast-feeding , ask a doctor before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
Adults and children 12 years of age and older: Take 1 or 2 tablets daily
Children Under 12 years of age: Do not use, Consult a doctor before use.
DOCUPRENE
docusate sodium tablet |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Labeler - Pharmaceutica North America, Inc. (962739699) |